Clinical Trial Update: Assessment of the Subcutaneous Reinjection of Human Autologous Adipose-derived Stromal Vascular Fraction (Celution® System) in the Hands of Patients Suffering From Systemic Sclerosis [NA]

View source ↗

Summary

Clinical trial update reporting the completion of a study evaluating subcutaneous reinjection of autologous adipose-derived stromal vascular fraction using the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Sclerosis

Drugs mentioned

• Celution System autologous adipose-derived stromal vascular fraction reinjection (adipose-derived stromal vascular fraction (SVF) reinjection)

Snippet

Sponsor: Assistance Publique Hopitaux De Marseille | Conditions: Systemic Sclerosis | NA | Status: COMPLETED